CSRO News

Displaying results 1-10 (of 77)
 |<  < 1 2 3 4 5 6 7 8  >  >| 

CSRO offers Federal Policy Virtual “Town Hall” to Rheumatology Community

The gridlock immobilizing Congress has slowed the progress of health care legislation significantly, but it has not stopped key Federal agencies from proposing and implementing policies that have a far reaching impact on the practice of rheumatology.

READ MORE

CSRO Comments on Proposed Rule to Eliminate Safe Harbor Protections for Prescription Drug Rebates

The Coalition of State Rheumatology Organizations (CSRO) recently submitted comments on the Department of Health and Human Services (HHS) proposed rule amending the Federal anti-kickback statute.

READ MORE

CSRO’s Dr. Robert Levin Discusses Drug Pricing in the U.S.

CSRO Board Member, Robert Levin, participated in the Healthcare Policy podcast on February 18 to discuss federal prescription drug pricing reform. In his capacity as a practicing physician, and president the Alliance for Transparent and Affordable Prescriptions, Dr. Levin provided expert testimony on drug pricing reform proposals and how the drug supply chain works.

READ MORE

The CSRO Holds Fellows Conference with Record Attendance

On February 9, 2019, the CSRO held its annual Fellows Conference in San Francisco, complete with a number of presentations on topics that surround today’s Rheumatologist.

READ MORE

CSRO Policy Update, January 2019, Issue 8

As the new year begins, I would like to reflect on the tremendous organizational successes that CSRO achieved in 2018. Over the past couple of years, CSRO made a commitment to deepening its ties with the societies it represents, and its allied patient and provider organizations. This year CSRO traveled to 20 state society meetings to bring increased awareness to the issues impacting practicing rheumatologists and patients in the U.S.

READ MORE

CSRO Submits IPI Comments

Prior to commenting on the proposed International Pricing Index Model (IPI) for Part B drugs, CSRO leadership met with Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma to convey rheumatology's perspective.

READ MORE

CSRO Talks Accumulator Adjustment Programs at CBI Summit

Accumulator Adjustment Programs have become an increasingly prevalent issue since CSRO was first made aware of them in late 2017. Since then, the programs have been progressively crossing over from the employer to commercial space.

READ MORE

CSRO Hosts State Society Leaders at the ACR

On Monday, October 22nd, CSRO hosted a breakfast for state rheumatology society leaders present at the ACR. Attendees had the opportunity to learn more about emergent patient access issues, CSRO’s plans for 2019, and hear from a speaker who discussed implementation and compliance issues with existing patient access laws.

READ MORE

CSRO Discusses New Drug Payment Model with Key Agency Officials

Last week, CSRO’s Past President and National Advocacy Chair, Michael Schweitz, MD, participated in one-on-one discussions with Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma and Special Advisor to the Administrator Jeet Guram, MD, to discuss details about the Trump Administration’s potential International Pricing Index Model for Medicare Part B Drugs.

READ MORE

New Data Emerges on Co-Pay Accumulator Programs

The CSRO has been deeply concerned about the expanded implementation of a new utilization management tool known as co-pay accumulator programs over the course of 2018.

READ MORE

Displaying results 1-10 (of 77)
 |<  < 1 2 3 4 5 6 7 8  >  >|